Clinical Trials
6 trialsNCT03613181 2023-04-24
ANGLeD
Angiochem Inc
Phase 3 Unknown
NCT01967810 2020-02-25
ANG1005 in Patients With Recurrent High-Grade Glioma
Angiochem Inc
Phase 2 Completed
NCT02048059 2020-02-25
ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
Angiochem Inc
Phase 2 Completed
NCT01497665 2019-01-22
GRABM-L
Angiochem Inc
Phase 2 Terminated
NCT01480583 2016-07-13
GRABM-B
Angiochem Inc
Phase 2 Completed
NCT00539383 2014-07-31
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer
Angiochem Inc
Phase 1 Completed